Sector revisions VYNE Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-15 pm EDT			5-day change	1st Jan Change
0.6700 ^USD	-0.06%		+1.42%	+15.50%

May. 15	VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Feb. 27	VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
VYNE THERAPEUTICS INC.				1
ARGENX SE				15
WUXI APPTEC CO., LTD.				17
INSMED INCORPORATED				20
BIONTECH SE				17
WUXI BIOLOGICS (CAYMAN) INC.				21
GENMAB A/S				15
AKESO, INC.				21
SUMMIT THERAPEUTICS INC.				13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
EXELIXIS, INC.				17
MADRIGAL PHARMACEUTICALS, INC.				14
ARROWHEAD PHARMACEUTICALS, INC.				12
PHARMAESSENTIA CORPORATION				6
CYTOKINETICS, INCORPORATED				19
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
IMMUNITYBIO, INC.				4
REMEGEN CO., LTD.				15
NUVALENT, INC.				18
Average				14
Weighted average by Cap.				16